The FDA refused to accept uniQure's filing for AMT-130 last November, and earlier this year the Dutch biotech said it had ...

Details are starting to emerge of last week's cyberattack on Novo Nordisk, which now appears to have been a $25 million ...

Moderna is hoping to launch three new vaccines in the next couple of years – including a flu shot that will come in front of ...

This article was developed and funded by Gilead Sciences Ltd. For decades, the UK life sciences sector has been the jewel in ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Andrew Cavey, CEO of ITM, about current and future ...

Jazz Pharma has made a big move into T-cell engagers (TCEs) for cancer, via an alliance with AbCellera that spans up to five candidates that could each generate milestones of up to $792 million.

The late-stage MonumenTAL-3 trial of Talvey (talquetamab), given in combination with J&J and Genmab's anti-CD38 antibody ...

A new study will attempt to improve screening for one of the fastest-growing drug-resistant bacterial threats facing ...

Poolbeg Pharma is preparing to start a clinical trial of a drug that aims to block a life-threatening side effect of cancer ...

A UK study has used dispensing data to understand how medicine use in England changed during and after the COVID-19 pandemic, ...

Eisai has been given a grant from the UK government that will be used to expand a facility in Hatfield, Hertfordshire, which ...

Across the US, the UK, and parts of Europe, CGT progress is being held back by an inability to secure starting material ...